Man-made blood vessels developed by researchers at Duke University, Yale University and the tissue engineering company Humacyte appear to be both safe and more durable than commonly used synthetic versions in patients undergoing kidney dialysis, the researchers report.
The findings, published May 12 in The Lancet, resulted from a phase 2 study among 60 patients with kidney failure who required dialysis, which often requires a synthetic graft when the patient’s own blood vessel degrades from frequent needle sticks.
Such grafts, however, are prone to infection, clotting, and other complications. And alternative bioengineered grafts derived from the patient, a donor, or animal tissue have been shown to perform no better than synthetics.
The Duke and Yale research team — along with surgeons in Poland and the United States and scientists at Humacyte, which is developing the bioengineered vessel — tested a human acellular vessel, or HAV, that is manufactured to be available to patients on demand, rather than made-to-order using an individual’s own cells.
“The bioengineered blood vessel represents a critical step in tissue engineering,” said Jeffrey Lawson, M.D., Ph.D., professor of surgery and pathology at Duke and chief medical officer of Humacyte. “Because these vessels contain no living cells, patients have access to off-the-shelf engineered grafts that can be used without any waiting period associated with tailor-made products.”
Lawson and co-author Laura Niklason, M.D., Ph.D., professor of anesthesiology and biomedical engineering at Yale, are principals of Humacyte, Inc., which supported the clinical trial.
To create the vessels, the researchers first isolated vascular cells from human donors and grew them in tissue culture. They then placed the cells on a degradable scaffold shaped like a blood vessel. As the tissue grew, it was bathed in nutrients and stretched to acquire the physical properties of real blood vessels.
“After that process, which takes eight weeks, the scaffold degrades and what we have left is engineered tissue that we have grown from scratch,” Niklason said.
The final step was to wash away the cells with a special solution. The remaining “de-cellularized” tissue retains the structure of the vessel but none of the components that would cause tissue rejection.
One year after implantation, the bioengineered vessels appeared to be both safe and functional, maintaining their mechanical integrity, the researchers report. The patients also showed no sign of rejection.
While there were cases of adverse events such as clotting, the rates of those events were comparable to other dialysis grafts. Notably, the durability of the bioengineered vessels at one year was 89 percent, compared to the approximately 60-percent rate of synthetic grafts reported in previous studies.
Additionally, the researchers noted that after implantation, the bioengineered vessels had been repopulated with the patient’s own cells, so nonliving tissue became living over time.
“The fact that an implanted acellular tube becomes a living human tissue has implications for regenerative medicine in a very profound way,” Lawson said.
The Latest on: Bioengineered Blood Vessel
via Google News
The Latest on: Bioengineered Blood Vessel
- Bioprinting Yields Promising Results for Treatment of Erectile Dysfunctionon June 15, 2020 at 7:10 am
More new blood vessels were found in the heparin-coated ... “Our work represents a significant step towards developing bioengineered vascularized corpora. It is the first report on 3D printed ...
- UW Spinout, Beat BioTherapeutics, Aims to Make Stem Cells for Damaged Heartson June 10, 2020 at 5:00 pm
BeatBio plans to deliver them via catheter, with a type of bioengineered scaffolding ... heart cells will draw support from blood vessels, and thrive on their own, Ratner says.
- Scientists 3D Printed Ears Inside Living Mice Using Lighton June 9, 2020 at 7:01 am
Depending on the cell type, they can then repair damaged spinal cords, nerve fibers, or blood vessels. In this study ... providing it with nutrients for long-term survival. For now, the bioengineered ...
- Lab-engineered liver cells are the first step to growing replacement liverson June 8, 2020 at 5:00 pm
They then added immature human liver cells as well as cells vital for the creation of new blood vessels ... don't count on one of these bioengineered organs coming to the rescue anytime soon.
- Fresh hope for heart disease patientson June 6, 2020 at 5:00 pm
Scientists have grown new blood vessels from human cells in a worldfirst ... Doctors say the 'bioengineered' arteries will be routinely implanted in patients with heart disease within ten years.
- Conference Report - Stem Cells and Tissue Engineering -- Dreaming Things That Never Wereon June 1, 2020 at 5:00 pm
Vascular surgeons achieve the replacement of blood vessels with autologous ... improves the mechanical properties of the bioengineered vessel. As noted by Dr. West, such a procedure is more ...
- Phase I trials at UC examine safety of immunotherapies for canceron May 1, 2019 at 8:57 am
Only offered locally at UC, these trials will study bioengineered antibodies being used to stimulate ... Matacic for a story that looks at the impact COVID-19 has on blood vessels in the body.
- Specialized wound care available close to homeon February 7, 2019 at 4:44 pm
Wound Center patients are treated using evidence-based therapies and technologies including, compression therapy, diabetic foot management, bioengineered tissue ... have shown an increased growth of ...
- Ethical Cells Build Working Kidneyon August 6, 2018 at 1:13 pm
His team then introduced kidney and blood vessel cells from newborn rats onto ... but it could lead to bioengineered kidneys one day replacing diseased or damaged kidneys in the same way that ...
- Bobby Robbinson September 21, 2015 at 1:10 pm
His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices.
via Bing News